THTI [THT Heat Transfer Technology] 8-K: THT Heat Transfer Technology, Inc. Announces Second Quarter

[THT Heat Transfer Technology, Inc. Announces Second Quarter 2015 Results SIPING, CHINA — August 14, 2015 — THT Heat Transfer Technology, Inc. (NASDAQ:THTI, “the Company”, or “THT”), a leading provider of heat exchangers and heat exchange solutions in China’s clean technology industry, today announced its unaudited financial results for the second quarter ended June 30, 2015. Second Quarter 2015 Financial] [FORM 8-K CURRENT REPORT August 14, 2015 Date of Report (Date of Earliest event Reported): THT HEAT TRANSFER TECHNOLOGY, INC. Nevada 001-34812 20-5463509 (State or other jurisdiction (IRS Employer Identification No.) of incorporation or organization) THT Industrial Park No.5 Nanhuan Road, Tiexi District 86-434-3265241 ___________________________________________________ 1 see 2 Item 2.02. Results of Operations and Financial Condition. Item 7.01. Regulation FD]

By | 2016-03-15T13:56:32+00:00 August 14th, 2015|Categories: Chinese Stocks, THTI, Webplus ver|Tags: , , , , , |0 Comments

VIPS [Vipshop] 6-K: Vipshop Reports Unaudited Second Quarter 2015 Financial Results

[Vipshop Reports Unaudited Second Quarter 2015 Financial Results 2Q15 Total Net Revenue Up 77.6% YoY to RMB9.0 Billion (US$1.5 Billion) 2Q15 Income from Operations Up 192.5% to RMB437.8 Million (US$70.6 Million) 2Q15 Net Income Attributable to Shareholders Up 147.2% to RMB399.3 Million (US$64.4 Million) Conference Call to be Held at 8:00 AM U.S. Eastern Time on August 11, 2015 Guangzhou,] [001-35454 Vipshop Holdings Limited No. 20 Huahai Street Liwan District, Guangzhou 510370 The People’s Republic of China Form 20-F x o o o Vipshop Holdings Limited By]

By | 2016-04-01T11:27:14+00:00 August 14th, 2015|Categories: Chinese Stocks, VIPS, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMA] 10-Q: FORM 10-Q (Mark One) x June 30, 2015

[FORM 10-Q (Mark One) x June 30, 2015 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Nevada 75-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 14, 2015 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321063015.htm]

By | 2016-03-28T19:16:55+00:00 August 14th, 2015|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

SNP [CHINA PETROLEUM & CHEMICAL] 6-K: This Form 6-K consists of: (a joint stock

[This Form 6-K consists of: (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 0386) NOTICE OF BOARD MEETING This is to announce that a meeting of the board of directors (the “Board”) of China Petroleum & Chemical Corporation (“Sinopec Corp.”) will be held from Tuesday, 25 August 2015 to Wednesday, 26]

By | 2016-03-23T06:42:49+00:00 August 14th, 2015|Categories: Chinese Stocks, SNP, Webplus ver|Tags: , , , , , |0 Comments

IDI [IDI] S-3:

[] [Nason, Yeager, Gerson White & Lioce, P.A. 1645 Palm Beach Lakes Blvd., Suite 1200 West Palm Beach, FL 33401 August 14, 2015 IDI, Inc. 2650 North Military Trail, Suite 300 Boca Raton, Florida 33431 Attention: Derek Dubner Co-Chief Executive Officer IDI, Inc. Registration Statement on Form S-3 Dear Mr. Dubner: In connection with this opinion, we have examined such documents] [INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT LLP Marcum Bernstein & Pinchuk New York, New York August 14, 2015 EX-23.1 3 d81344dex231.htm EX-23.1] [Consent of Independent Auditors We consent to the incorporation by reference in the registration statement on Form S-3 of IDI, Inc. of our report, dated July 8, 2015, relating to our audits of the financial statements of IDI Holdings, LLC as of and for the period from September 22, 2014 (inception) through December 31, 2014, which are included in the]

By | 2016-03-13T15:13:53+00:00 August 14th, 2015|Categories: Chinese Stocks, IDI, Webplus ver|Tags: , , , , , |0 Comments

WX [WuXi PharmaTech (Cayman)] 6-K: The Company’s board of directors, acting upon the

[The Company’s board of directors, acting upon the unanimous recommendation of the special committee formed by the board of directors (the “Special Committee”), unanimously approved the Merger Agreement and the transactions contemplated by the Merger Agreement, including the Merger, and resolved to recommend that the Company’s shareholders authorize and approve the Merger Agreement and the transactions contemplated by the Merger] [EXECUTION VERSION AGREEMENT AND PLAN OF MERGER among NEW WUXI LIFE SCIENCE LIMITED, WUXI MERGER LIMITED and WUXI PHARMATECH (CAYMAN) INC. Dated as of August 14, 2015 TABLE OF CONTENTS Page ARTICLE I THE MERGER 2 Section 1.01 The Merger 2 Section 1.02 Closing; Closing Date 2 Section 1.03 Effective Time 2 Section 1.04 Effects of the Merger 2 Section] [Form 6-K Description Press release dated August 14, 2015 Agreement and Plan of Merger among WuXi PharmaTech (Cayman) Inc., New WuXi Life Science Limited and WuXi Merger Limited, Dated August 14, 2015 2 WuXi PharmaTech (Cayman) Inc. Edward Hu Chief Financial Officer 3 6-K 1 d47457d6k.htm FORM 6-K]

By | 2016-03-24T02:27:41+00:00 August 14th, 2015|Categories: Chinese Stocks, Webplus ver, WX|Tags: , , , , , |0 Comments

ACTS [Actions Semiconductor] 6-K: Actions Semiconductor Reports Second Quarter 2015 Results ZHUHAI,

[Actions Semiconductor Reports Second Quarter 2015 Results ZHUHAI, China, August 14, 2015 — Actions Semiconductor Co., Ltd. (Nasdaq: ACTS) Commenting on the second quarter results, Dr. Zhenyu Zhou, CEO of Actions Semiconductor said, “Revenue in the second quarter came in at the high end of our expectations and we achieved a meaningful improvement in gross margin. Sales of our multimedia] []

By | 2016-03-19T16:37:26+00:00 August 14th, 2015|Categories: ACTS, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

CPGI [China Shengda Packaging] 10-Q: FORM 10−Q (Mark One) [X] June 30, 2015

[FORM 10−Q (Mark One) [X] June 30, 2015 For the quarterly period ended: [ ] For the transition period from ____________to _____________ 001-34997 CHINA SHENGDA PACKAGING GROUP INC. Nevada 26-1559574 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) No. 2 Beitang Road People’s Republic of China Xiaoshan Economic and Technological Development Zone (86) 571-82838805 _____________________________________________________ Large] [CERTIFICATIONS I, Daliang Teng, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Shengda Packaging Group Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ken He, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Shengda Packaging Group Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. Daliang Teng Chief Executive Officer] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. Ken He Chief Financial Officer (Principal Financial Officer)]

By | 2016-03-31T02:49:16+00:00 August 14th, 2015|Categories: Chinese Stocks, CPGI, Webplus ver|Tags: , , , , , |0 Comments

CBAK [CHINA BAK BATTERY] NT 10-Q: FORM 12b-25 NOTIFICATION OF LATE FILING (Check one):

[FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): CUSIP NUMBER [ For Period Ended: June 30, 2015 [ Transition Report on Form 10-K [ Transition Report on Form 20-F [ Transition Report on Form 11-K [ Transition Report on Form 10-Q [ Transition Report on Form N-SAR For the Transition Period Ended: Nothing in this form shall be construed to]

CCCR [China Commercial Credit] 10-Q:

[] [I, Jingen Ling, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended June 30, 2015 of China Commercial Credit, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [I, Long Yi, certify that: 1 I have reviewed this quarterly report on Form 10-Q for the period ended June 30, 2015 of China Commercial Credit, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 906 OF SARBANES-OXLEY ACT OF 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jingen Ling Chief Executive Officer] [SECTION 906 OF SARBANES-OXLEY ACT OF 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Long Yi Chief Financial Officer (Principal Financial and Accounting Officer)]

By | 2016-03-16T17:29:51+00:00 August 14th, 2015|Categories: CCCR, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar